Group One Trading
RIGL icon

Group One Trading’s Rigel Pharmaceuticals RIGL Stock Holding History

Group One Trading’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.6K Sell
2,500
-900
-26% -$30.2K ﹤0.01% 5042
2025
Q4 		$146K Sell
3,400
-7,100
-68% -$268K ﹤0.01% 4655
2025
Q3 		$297K Buy
10,500
+3,800
+57% +$114K ﹤0.01% 4236
2025
Q2 		$125K Buy
6,700
+4,500
+205% +$85.3K ﹤0.01% 4769
2025
Q1 		$39.6K Buy
+2,200
New +$44.6K ﹤0.01% 5333
2024
Q4 		– Sell
-18,000
Closed -$291K – 7853
2024
Q3 		$291K Sell
18,000
-85,600
-83% -$1.01M ﹤0.01% 3289
2024
Q2 		$852K Buy
103,600
+87,640
+549% +$917K ﹤0.01% 2134
2024
Q1 		$236K Sell
15,960
-3,120
-16% -$42K ﹤0.01% 3413
2023
Q4 		$277K Buy
19,080
+2,220
+13% +$22.7K ﹤0.01% 3575
2023
Q3 		$182K Sell
16,860
-680
-4% -$8.18K ﹤0.01% 3888
2023
Q2 		$226K Buy
17,540
+6,420
+58% +$86.8K ﹤0.01% 3801
2023
Q1 		$147K Sell
11,120
-2,410
-18% -$38.3K ﹤0.01% 3951
2022
Q4 		$203K Buy
13,530
+1,860
+16% +$17.1K ﹤0.01% 3853
2022
Q3 		$138K Sell
11,670
-2,780
-19% -$37.6K ﹤0.01% 4479
2022
Q2 		$163K Buy
14,450
+3,630
+34% +$72.9K ﹤0.01% 4497
2022
Q1 		$324K Sell
10,820
-150
-1% -$4.06K ﹤0.01% 4290
2021
Q4 		$291K Sell
10,970
-5,070
-32% -$153K ﹤0.01% 4690
2021
Q3 		$582K Buy
16,040
+10,680
+199% +$420K ﹤0.01% 4019
2021
Q2 		$233K Sell
5,360
-7,930
-60% -$299K ﹤0.01% 5073
2021
Q1 		$455K Buy
13,290
+370
+3% +$14.7K ﹤0.01% 4152
2020
Q4 		$452K Buy
12,920
+6,480
+101% +$188K ﹤0.01% 3351
2020
Q3 		$155K Buy
6,440
+4,500
+232% +$110K ﹤0.01% 3855
2020
Q2 		$36K Buy
1,940
+1,860
+2,325% +$33.5K ﹤0.01% 4555
2020
Q1 		$1K Buy
+80
New +$1.7K ﹤0.01% 5102
2019
Q4 		– Sell
-1,280
Closed -$24K – 5532
2019
Q3 		$24K Sell
1,280
-2,240
-64% -$46.3K ﹤0.01% 4305
2019
Q2 		$92K Sell
3,520
-370
-10% -$8.35K ﹤0.01% 3420
2019
Q1 		$100K Sell
3,890
-10,070
-72% -$230K ﹤0.01% 3178
2018
Q4 		$321K Buy
13,960
+8,750
+168% +$247K ﹤0.01% 2325
2018
Q3 		$167K Sell
5,210
-6,340
-55% -$190K ﹤0.01% 3143
2018
Q2 		$327K Buy
11,550
+2,100
+22% +$74.7K ﹤0.01% 2652
2018
Q1 		$335K Buy
9,450
+2,970
+46% +$119K ﹤0.01% 2363
2017
Q4 		$251K Buy
6,480
+3,670
+131% +$140K ﹤0.01% 2786
2017
Q3 		$71K Buy
2,810
+1,830
+187% +$44.5K ﹤0.01% 3444
2017
Q2 		$27K Sell
980
-270
-22% -$7.39K ﹤0.01% 3827
2017
Q1 		$41K Sell
1,250
-5,980
-83% -$152K ﹤0.01% 3518
2016
Q4 		$172K Sell
7,230
-4,440
-38% -$127K ﹤0.01% 2523
2016
Q3 		$428K Buy
11,670
+11,550
+9,625% +$331K ﹤0.01% 1928
2016
Q2 		$3K Sell
120
-980
-89% -$24.4K ﹤0.01% 4374
2016
Q1 		$23K Sell
1,100
-680
-38% -$16.8K ﹤0.01% 3677
2015
Q4 		$54K Buy
1,780
+1,420
+394% +$43.1K ﹤0.01% 3358
2015
Q3 		$9K Buy
+360
New +$10.7K ﹤0.01% 4339
2015
Q2 		– Sell
-3,910
Closed -$140K – 5120
2015
Q1 		$140K Buy
+3,910
New +$107K ﹤0.01% 2651
2014
Q3 		– Sell
-1,740
Closed -$63K – 5405
2014
Q2 		$63K Sell
1,740
-790
-31% -$26.9K ﹤0.01% 3383
2014
Q1 		$98K Buy
2,530
+1,240
+96% +$44.2K ﹤0.01% 3103
2013
Q4 		$37K Sell
1,290
-1,040
-45% -$30.5K ﹤0.01% 3843
2013
Q3 		$83K Sell
2,330
-1,260
-35% -$46K ﹤0.01% 3173
2013
Q2 		$120K Buy
+3,590
New +$163K ﹤0.01% 2647

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's RIGL Position: Q1 2026 in Review

Group One Trading sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 638 shares — an estimated $21.4K sold.

Group One Trading first reported a position in RIGL in Q3 2013 and held it in 23 quarters. The position peaked at $448K in Q3 2021. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Group One Trading reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 638 Rigel Pharmaceuticals shares in Q1 2026, an estimated $21.4K.
  • Group One Trading first reported a position in Rigel Pharmaceuticals in Q3 2013 and held it in 23 quarters.
  • Group One Trading's Rigel Pharmaceuticals position peaked at $448K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.